Advanced in Peripheral T-Cell Lymphoma

Ute Hegenbart

Heidelberg, BW, DE 
Advanced in Peripheral T-Cell Lymphoma
Heidelberg, BW, DE 
OverviewLocationsClinical Research

Overview

Ute Hegenbart practices in Heidelberg, Germany. Ms. Hegenbart is rated as an Advanced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Her top areas of expertise are Primary Amyloidosis, Familial Transthyretin Amyloidosis, Transthyretin Amyloidosis, Bone Marrow Transplant, and Heart Transplant.

Her clinical research consists of co-authoring 189 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Peripheral T-Cell Lymphoma.

Gender
Female

Locations

Heidelberg, BW, Germany
Other Locations
Halle, NI, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma. A Phase II Study (Allo-MM-PostCy-Study)
Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma. A Phase II Study (Allo-MM-PostCy-Study)
Enrollment Status: Completed
Publish Date: March 30, 2025
Intervention Type: Drug
Study Drug: Cyclophosphamide
Study Phase: Phase 2
Randomized Phase III Study Comparing Conventional Chemotherapy to Low Dose Total Body Irradiation-Based Conditioning and HCT From Related and Unrelated Donors as Consolidation Therapy for Older Patients With AML in 1st Complete Remission
Randomized Phase III Study Comparing Conventional Chemotherapy to Low Dose Total Body Irradiation-Based Conditioning and HCT From Related and Unrelated Donors as Consolidation Therapy for Older Patients With AML in 1st Complete Remission
Enrollment Status: Terminated
Publish Date: October 14, 2021
Intervention Type: Drug, Procedure
Study Phase: Phase 3
View 1 Less Clinical Trial

189 Total Publications

Retrospective analysis of a patient cohort with suspicion of systemic amyloidosis, finally not confirmed
Retrospective analysis of a patient cohort with suspicion of systemic amyloidosis, finally not confirmed
Journal: Deutsche medizinische Wochenschrift (1946)
Published: August 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hegenbart's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile